// App-Quantinova.ai

3094 : Anticancer drugs associated with venous thromboembolic event: Analysis of the WHO pharmacovigilance database.

Researchers

Presenter

  • Anglique DA Silva

Principal Investigators

  • Joachim Alexandre

  • Damien Laneelle

  • Marion Sassier

  • Basile Chrtien

  • Sophie Fedrizzi

  • Florence Joly

  • George Emile

  • Laurent Bertoletti

  • Benoite Mery

  • Anne Flore Plane

  • Damien Legallois

  • Charles Dolladille

Medical Centers

  • PICARO Cardio-oncology Program, Breast Cancer Unit, Centre François Baclesse, Caen, France

  • CHU De Caen Normandie, Picaro Cardio-Oncology Program, Department of Pharmacology, EA 4650, Signalisation, Électrophysiologie Et Imagerie Des Lésions D'ischémie-Reperfusion Myocardique, Caen, France

  • Vascular Medicine, CHU de Caen Normandie, Caen, France

  • PICARO Cardio-oncology Program, Department of Pharmacology, CHU de Caen, Caen, France

  • Dept. of Medical Oncology, Centre Francois Baclesse, Caen, France

  • Breast Cancer Unit, Centre François Baclesse, Caen, France

  • Service de Médecine Vasculaire et Thérapeutique, CHU de Saint-Etienne, Saint-Etienne, France.

  • Institut de Cancerologie Lucien Neuwirth, Saint-Priest en Jarez cedex, France.

  • CHU de Caen Normandie, PICARO Cardio-oncology Program, Department of Cardiology, Caen, France

  • CHU de Caen Normandie, PICARO Cardio-oncology Program, Department of Cardiology, Caen, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Sipuleucel-T

  • Bevacizumab

  • Thalidomide

  • Megestrol acetate

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • NCT04696250

Sponsors

  • N/A

Result

  • N/A